First Line Acne Treatment: Comparison of Cost and Efficacy

Authors

Michael P. McNeilFollow
Karlen E. Luthy, Brigham Young UniversityFollow
Christine R. Platt, University of ArizonaFollow
Michael S. Robinson, Brigham Young UniversityFollow
Janelle L.B. Macintosh, Brigham Young UniversityFollow

Keywords

acne vulgaris, retinoids, benzoyl peroxide, clindamycin, cost-benefit analysis

Abstract

Acne vulgaris is a common skin concern that may cause permanent disfiguration and encumbering effects on self-esteem and mental health. Additionally, it is often associated with expensive treatment costs for patients. When selecting the most appropriate therapeutic approach, nurse practitioners must also consider the price of the medication. For the majority of mild to moderate cases of acne (both comedonal and inflammatory), effective first-line treatment recommendations include a combination of a topical retinoid, benzoyl peroxide, and a topical antibiotic such as clindamycin. Generic and compounded medications are typically more cost-effective for patients than brand name formulations.

BYU ScholarsArchive Citation

McNeil, Michael P.; Luthy, Karlen E.; Platt, Christine R.; Robinson, Michael S.; and Macintosh, Janelle L.B., "First Line Acne Treatment: Comparison of Cost and Efficacy" (2023). Student Works. 344.
https://scholarsarchive.byu.edu/studentpub/344

Document Type

Master's Project

Publication Date

2023-06-16

Language

English

College

Nursing

Department

Nursing

University Standing at Time of Publication

Graduate Student

Copyright Use Information

https://lib.byu.edu/about/copyright/